AnGes Starts Japan's 1st Clinical Trial of COVID-19 Vaccine

AnGes Starts Japan's 1st Clinical Trial of COVID-19 Vaccine

   Osaka, June 30 (Jiji Press)--Japanese pharmaceutical startup AnGes Inc. said Tuesday that it has started a clinical trial of a potential vaccine for COVID-19.
   The clinical trial, the first in Japan for the coronavirus disease, will be participated in by 30 healthy adults at Osaka City University Hospital.

To read a full story, please click here to find out how to subscribe.

(C)JIJI PRESS LTD., All rights reserved.